Plants have been the target of research for a long period because of their unique properties. Due to the side effects that synthetic drugs might elicit, there is an increasing demand for traditional medicine as an alternative. Besides, bioactive components of plant extracts including different monoterpenoids, sesquiterpenoids, diterpenoid, flavonioids, fatty acids, and lignans have attracted the attention of scientists. [1] [2] [3] [4] [5] [6] [7] . HSV1, a member of Herpesviridae can cause disease ranging from Herpes Labialis to severe encephalitis. Herpes infection can also cause severe diseases in neonates, elderly, transplanted patients immuno suppressed by drugs and in patients with acquired immune deficiency syndrome. Resistance to current anti-herpetic drugs has been increasingly reported [8, 9] . This mandates the need to search for new therapeutic tools. This encouraged us to investigate anti-HSV1 effects of Iranian Artemisia. The genus Artemisia L is one of the largest and most widely distributed of the Astraceae (Compositae) family. This is a large and heterogeneous genus, numbering over 400 species distributed mainly in the temperate zone of Europe, Asia, and North America [10] [11] [12] [13] [14] . The genus in Iran has 34 species, two of which are endemic to this country [14] [15] [16] . Different species of Artemisia have a vast range of biological effects including anti-malarial [17] [18] [19] [20] , anti-bacterial, anti-fungal [17] [18] [19] [21] [22] [23] , and anti-oxidant [18] [19] [20] [21] [22] [23] [24] [25] [26] . Besides, there have been some reports on the inhibitory activity of Artemisia species against some types of viruses including HSV1 [27] [28] [29] [30] [31] . Therefore, the present study aimed to investigate the in vitro anti-HSV1 activities of extracts obtained from the aerial subsets of Iranian Artemisia species.
Methods

Plant material
Seven species of Artemisia were collected from different parts of Iran ( Table 1) . The Research Institute of Forest and Rangelands, Ministry of Jahad-E-Agriculture Iran identified these plants. Voucher specimens of the species have been deposited in the Herbarium of National Botanical Garden of Iran (TARI).
Cell Culture
HeLa cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS, Gibco), penicillin G (100 U/mL), streptomycin (100 μg/mL), and amphotricin B (25 μg/mL). The cells were incubated under a humid 5% CO 2 atmosphere at 37
Extraction procedure
The dried aerial parts of each species (100 g) were chopped in small pieces and then crushed into powder by a blender. Each sample was macerated in pure methanol for 24 hours. The samples were then extracted using a percolator (10 hours, 30 drops/min) [32] . The extracts were concentrated by a rotary evaporator and dried in an oven at 50 C under reduced pressure to give 5-8 g. of solid residue. The solid residues (0.2 g) were dissolved in 100 mL of phosphate buffer containing 0.1% of ethanol, filtered, and sterilized using 0.22μ microbiological filters. Serial dilutions were prepared so that the concentrations of extracts were 400, 200, 100, 50, 25, 12.5, 6.25, and 3.125 μg/mL. The extracts were kept in the sterilized bottles in the fridge.
Evaluation of viral efficacy to infect the cells
To evaluate whether the preparation could infect cells, HeLa cells were cultured on the flat bottom of 96 well plates. Two hundred L of HeLa cells preparation containing 10 4 cells was transferred into each well and incubated at 37 Ο C for 24 hours. Then, 180 l of the supernatant was removed and the cells were covered by 180 μL of viral preparation containing 5x10 6 pfu/mL of HSV1 and incubated for 24 hours. Afterwards, 200 μL of culture media was removed and replaced by 200 μL of fresh culture media and 20 μL of MTT. The plates were covered by aluminum foil roundly and incubated for four hours at 37 Ο C. Then, wells were emptied and 200 μL of dimethyl sulphoxide (DMSO) and 15 μL of glycin buffer were added. The dye absorption by viable cells was measured by ELISA reader and compared to the control wells that contained only Hela cells. The ratio of the infected cells to uninfected cells was an indicator for anti-viral effectiveness.
Evaluation of anti-viral effect of extracts
A cell preparation containing 10 4 cells was passed into each 96 wells flat bottom plate. Twenty-four hours later, 100 L of a viral preparation containing 5x10 6 pfu/mL of HSV1 (KOS strain) in fresh culture media was transferred into each well. KOS 
Results
Evaluation of the viral infectivity
This experiment showed that the viral suspension was able to infect the HeLa cells and it can be used for the next experiments.
Anti-viral activities of plant extracts among Artemisia species
We investigated anti-HSV1 activity of subset extracts obtained from aerial parts of Artemisia belonging to Seriphidium section including A. incana, A. chamaemelifolia, A. campesteris, A. fragrans, A. annua, A. vulgaris, and A. persica. Methanolic extracts were tested at various concentrations. Results showed that the extracts of aerial parts of A. annua had the highest anti-herpetic activity. Those of A. chamaemelifolia showed the lowest activity. The highest protection rates of A. incana, A. chamaemelifolia, A .fragrens and A .persica methanolic extracts were observed at 12.5 μg/mL concentration being 50.69%, 46.53%, 60%, and 81.37%, respectively. The lowest protection rates of the aforementioned extracts were at 50 μg/mL concentration being 30.21%, 26.61%, 23%, and 25.69%, respectively. The protection rate decreased at higher concentrations in the aforementioned plant extracts particularly at concentration of 100, 200, and 400 μg/mL. The 100 μg/mL concentration showed very low activity against HSV1 and concentrations of 200 and 400 μg/ml showed cytotoxicity. The highest protection rates of A. campesteris, A. annua, and A. vulgaris methanolic extracts were observed at concentrations of 6.25, 12.5, and 25 μg/mL, which were 73.32%, 83%, and 63.94%, respectively. In these plants, the lowest protection rates were at concentrations of 50, 3.125, and 50 μg/mL being 24%, 69%, and 26%, respectively. Again, higher concentrations showed negligible protection rates (100 g/mL) or cytotoxicity (200 and 400 μg/mL) (Figs 1  & 2) . With respect to acyclovir, the highest protection rate was observed at 50 μg/mL being 81.43%, while the lowest protection rate was observed at 3.125 μg/ mL being 38.67%. The same as plant extracts, higher concentrations showed negligible protection (100 μg/ mL) or cytotoxicty (200 and 400 μg/mL).
Comparison of anti-viral activities of plant extracts with positive controls
HSV1-infected cells that were neither treated with extract nor with acyclovir served as positive control. The percentage of viable cells in the control well was 18%. Comparison between the protection rate of A. chamaemelifolia (the extract with weakest anti-HSV1 activity) and positive control indicated significant difference at all assessed concentrations (3.125, 6.25, 12.5, 25, and 50 μg/mL), with the viability being higher in the A. chamaemelifolia treated cells. Therefore, it may be deduced that other extracts are also associated with higher protection at these concentrations compared to positive control.
Comparison of anti-viral activities of plant extracts to acyclovir
In this research, anti-HSV1 activities of subset extracts obtained from aerial parts of Iranian Artemisia were investigated and compared with the anti-viral activity of acyclovir. A. annua extracts (as the strongest anti-viral extract) showed higher anti-HSV1 activities than acyclovir at 3.125, 6.25, 12.5, and 25 μg/mL concentrations. However, the anti-HSV1 activity of acyclovir was higher at 50 μg/mL than that of A. annua. A comparison of the anti-HSV1 activity of tested Artemisia extracts is shown in Table 2 .
Discussion
We evaluated the anti-viral activities of seven species of Artemisia simultaneously. For this purpose, HSV1-infected HeLa cells were incubated with different concentrations of Artemisia extracts. The results showed that the extract obtained from the aerial parts of A. annua has the highest anti-herpetic activity but A. chamaemelifolia extract showed the lowest activity. The protection rate, which was determined by the ratio of the viable cells to the dead cells, decreased at higher concentrations of the extracts. A 100 g/mL concentration showed very low activity against HSV1 and concentrations of 200 and 400 g/ mL showed cytotoxic effects as shown in Fig. 1 . There have been some previous reports on the antiviral activity of some Artemisia species. Saddi and colleagues reported the antiviral activity of essential oil obtained from the leaves of A. aborescens against HSV1 and HSV2 [27] . In another investigation, ChaoMei et al. reported the inhibitory effect of A. caruifolia methanolic extract against HIV1 protease and demonstrated that this effect could be attributed to the presence of tri-p-coumaroylspermidine [28] .
A. verlotorum aquous extract has also been demonstrated to exert strong activity against feline immunodeficiency virus (FIV), which is a reliable model of HIV1 [29] .
The anti-HSV1 properties of extracts from the medicinal plants used in this research could be due to multiple different components in these plants. The phytochemical characterization of extracts and the identification of bioactive compounds are now needed. Unknown is also the method of action of active components of subset from our extract extracts. The presence of flavones such as 4', 6, 7-trihydroxy-3', 5'-dimethoxyflavone and 5', 5-dihydroxy-3', 4', 8-trimethoxyflavone [20] , exiguaflavone A and B [33] , artemetin, bonanzin, eupalitin, and chrysosplenetin [34] in the extracts of Artemisia have been previously reported and anti-viral activities of flavones have been broadly demonstrated [35] . Some of these phytochemicals might be responsible for the anti-viral activity of Artemisia species used in this research. As for the A. annua, artemisinin (a safe and commonly used anti-malarial medication) is among the most important candidates accounting for the observed antiviral effects. In previous studies, artemisinin and its derivatives such as artesunate, have been shown to possess antiviral activities against a range of viruses including HSV1, human cytomegalovirus, Epstein-Barr virus, hepatitis B virus, hepatitis C virus, HIV1, and bovine viral diarrhea virus [30] . In addition, sterols including sitosterol and stigmasterol have been isolated from A. annua, as virus inhibitory agents [31] . Further studies have to be conducted to determine if there is a substantial difference or even any synergistic or antagonistic effect among different components existing in these medicinal plants, which can affect anti-viral activities. This work also needs to be expanded to other viruses and extended to studies in animal models.
In conclusion, extracts of A. annua and related species may be appropriate candidate for further therapeutic studies against herpes viruses.
